Cargando…

Development and validation of nomograms integrating immune‐related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple‐negative breast cancer: A gene expression‐based retrospective study

PURPOSE: Accumulating evidence indicated that triple‐negative breast cancer (TNBC) can stimulate stronger immune responses than other subtypes of breast cancer. We hypothesized that integrating immune‐related genomic signatures with clinicopathologic factors may yield a predictive accuracy exceeding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kang, Li, Hai‐Lin, Xiong, Yong‐Fu, Shi, Yang, Li, Zhu‐Yue, Li, Jie, Zhang, Xiang, Li, Hong‐Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382728/ https://www.ncbi.nlm.nih.gov/pubmed/30677255 http://dx.doi.org/10.1002/cam4.1880

Ejemplares similares

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
por: Hu, Mei-Di, et al.
Publicado: (2019)

PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis
por: Qin, Yuan, et al.
Publicado: (2021)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

Clinicopathological feature and prognosis of primary hepatic gastrointestinal stromal tumor
por: Liu, Zhen, et al.
Publicado: (2016)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
por: Huang, Jian, et al.
Publicado: (2020)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics
por: Sheng, Dan-li, et al.
Publicado: (2022)

Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population‐based study
por: Tian, Fang‐Xi, et al.
Publicado: (2018)

KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma
por: Liu, Yi, et al.
Publicado: (2020)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram
por: Wu, Zi-You, et al.
Publicado: (2020)

Development and validation of a clinicopathological‐based nomogram to predict seeding risk after percutaneous thermal ablation of primary liver carcinoma
por: An, Chao, et al.
Publicado: (2020)

Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2020)

Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature
por: Li, Jia-wei, et al.
Publicado: (2018)

Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients
por: Shi, Hao, et al.
Publicado: (2019)

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
por: Astvatsaturyan, Kristine, et al.
Publicado: (2018)

Prognosis in triple‐negative apocrine carcinomas of the breast: A population‐based study
por: Wu, Wenyu, et al.
Publicado: (2019)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
por: Yang, Yaping, et al.
Publicado: (2019)

Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern
por: Li, Ying-Zi, et al.
Publicado: (2022)

Comparison of epidemiological features, clinicopathological features, and treatments between premenopausal and postmenopausal female breast cancer patients in western China: a retrospective multicenter study of 15,389 female patients
por: Feng, Fan, et al.
Publicado: (2018)

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
por: Hashmi, Atif Ali, et al.
Publicado: (2014)

Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
por: Derkaoui, Touria, et al.
Publicado: (2016)

Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer
por: Feng, Wanting, et al.
Publicado: (2018)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
por: Liu, Hong, et al.
Publicado: (2019)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
por: Zhao, Yanding, et al.
Publicado: (2020)

Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non‐high‐incidence area
por: Xiao, Hai‐Fan, et al.
Publicado: (2020)

Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis
por: Lin, Chengjie, et al.
Publicado: (2017)

Radiotranscriptomics signature‐based predictive nomograms for radiotherapy response in patients with nonsmall cell lung cancer: Combination and association of CT features and serum miRNAs levels
por: Fan, Liyuan, et al.
Publicado: (2020)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
por: Guo, Lin-Wei, et al.
Publicado: (2018)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Up‐regulation of mir‐10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer
por: Jiang, Hong, et al.
Publicado: (2016)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6aajo2suplatbr9a5bt258dn0u